Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Visible Light Photocatalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN115894345A reveals a metal-free visible light method for chiral azaarene cyclobutanes, offering cost reduction in API manufacturing and high stereoselectivity.
Patent CN110467585A introduces a mild visible light method for benzothiazole derivatives, offering cost reduction and supply chain reliability for pharmaceutical intermediates.
Patent CN110590774B discloses a green photocatalytic method for C3-trifluoromethylation of imidazo-fused rings, offering mild conditions and high purity for pharmaceutical intermediates.
Patent CN110590774B details a green photocatalytic route for C3-trifluoromethylation, offering mild conditions and high purity for pharmaceutical intermediates.
Patent CN108456227B reveals efficient photocatalytic synthesis enabling cost reduction in pharmaceutical intermediates manufacturing with high regioselectivity.
Patent CN110028403A reveals visible light dicarboxylation. Offers mild conditions and scalable succinic acid manufacturing for pharma intermediates.
Patent CN115368238A reveals a catalyst-free visible light method for trans-olefins. Achieves >100:1 stereoselectivity at room temperature, offering significant cost reduction.
Patent CN111333558A details a catalyst-free visible light method for α-selenyl ketones. Discover cost-effective, scalable routes for high-purity pharmaceutical intermediates.
Novel visible-light method for high-purity pharmaceutical intermediates. Reduces cost and environmental impact significantly for global supply chains.
Patent CN113845427B reveals a green visible light method for aryl compounds. This report analyzes cost reduction and supply chain reliability for fine chemical intermediates manufacturing.
Patent CN109293541A enables room temperature synthesis. Reduces cost and improves supply chain reliability for pharmaceutical intermediates manufacturing globally.
Patent CN110551059B reveals a metal-free, visible-light driven synthesis of 3-sulfonylspiro[4,5]trienones using DABSO, offering significant cost reduction and supply chain stability.
Patent CN115057840B details a visible light-promoted synthesis of 3-acyl coumarins. This method offers cost reduction in fine chemical manufacturing and high-purity intermediates.
Patent CN107445795A reveals a visible-light photocatalytic method for fluorinated aryl blocks. Enables cost reduction in agrochemical manufacturing and high-purity supply.
Patent CN118084596B enables visible light catalytic hydrogenation of aromatic olefins. Achieve high-purity intermediates with reduced costs and mild reaction conditions for scalable manufacturing.
Novel visible-light synthesis of fluoroalkyl indolines using Eosin Y. Green chemistry, mild conditions, high yield for pharmaceutical intermediates.
Patent CN112442002A details a metal-free photocatalytic route for 11-sulfenyl naphtho[2,3-b]benzofuran. Discover cost-effective manufacturing and supply chain advantages.
Patent CN108017579A details metal-free quinoline synthesis via visible light. Offers high purity, mild conditions, and scalable supply chain solutions for global pharmaceutical manufacturers.
Novel visible-light driven synthesis method offers mild conditions and high purity for pharmaceutical intermediates, ensuring supply chain reliability and cost efficiency.
Novel photocatalyst-free method for high-purity homoallylamine intermediates using water and visible light, ensuring cost-effective and scalable manufacturing.